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The ribonuclease T, (RNase T,) gene was ligated to a synthetic gene for the signal peptide of Escherichiu coli alkaline phosphatase. When this 
fusion gene was expressed in E. cofi under the control of the rrp promoter, active RNase T, having the correct N-terminal sequence was secreted 
into the periplasmic space, indicating that the heterologous ignal peptide had been cleaved off correctly. The enzyme could be readily purified 
from the periplasmic fraction with a yield of 1.8 mg from 1 liter culture. Adopting the same strategy, it was possible to produce a labile mutant 
of RNase T, (Glu-58 + Ala mutant) in E. coli, the yield of the purified mutant enzyme being 2.0 mg from 1 liter culture. 
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1. INTRODUCTION 
Ribonuclease Ti (RNase Ti) from Aspergillus oryzae 
catalyzes specifically the hydrolysis of the 
phosphodiester bonds of guanosine 3’-phosphate 
residues in single-stranded RNA [l]. It has been used 
for RNA sequencing and its properties have been exten- 
sively studied [2,3]. 
We have chemically synthesized the RNase Ti gene 
and expressed it in E. coli [4]. By using protein 
engineering techniques, we have also analyzed the func- 
tional roles of residues involved in RNase Ti catalysis 
[5] and those required for recognition of guanine base 
[6-81. In an attempt to reduce the potentially toxic 
nucleolytic activity of RNase Ti and its mutant in E. 
cofi cells, we have constructed fusion proteins in which 
two-thirds of human growth hormone (hGH-AB) is 
connected to the N-terminus via a methionine residue 
[9], or hGH-AB and insulin-like growth factor I are 
ligated to the N- and C-termini of the enzymes, respec- 
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tively, again via methionine residues (sandwich 
method) [7]. These fusion proteins were efficiently ex- 
pressed in E. coli and RNase Ti and its mutants could 
be cut off from them by BrCN treatment. However, the 
drastic BrCN treatment resulted in poor yields of the 
enzymes, making it difficult to obtain sufficient quan- 
tities of the enzymes for physicochemical characteriza- 
tion. To solve this problem, we decided to employ the 
‘secretion methods’, which has allowed Quass et al. 
[lo] to produce nearly intact RNase Ti in E. cofi. 
Here we report the construction of an efficient secre- 
tion vector containing the gene for the signal peptide of 
E. cofi alkaline phosphatase (APase). By using this vec- 
tor, it was possible to accumulate wild-type RNase Ti 
and one of its mutants in the periplasmic space of E. 
coli, permitting their simple purification with high 
yields. 
2. MATERIALS AND METHODS 
2.1. Synth&s of signal peptide gene and construction of secretion 
plasmids 
Based on the known primary structure of the signal peptide of E. 
coli APase [11], oligodeoxyribonucleotides (Ul, U2, Ll and L2 in 
Fig. la) were synthesized by the phosphoramidite method in an Ap- 
plied Biosystems DNA synthesizer. In designing these 
oligonucleotides, codon usage in E. coli [12] was taken into account. 
These oligonucleotides were ligated and annealed as shown in Fig. 1 
to produce a synthetic gene for the signal peptide of APase. All DNA 
manipulations were performed as described previously [4]. pGH-L9 
containing the trp promoter and the hGH gene [9], was digested with 
C/a1 and SalI (Fig. lb). The linearized vector containing the trp pro- 
moter was isolated from a lolo agarose gel after electrophoresis. pPS- 
Tl (T. Tanaka and K. Ohara, unpublished results), which has been 
derived from pPShGHl1 [13] and contains the RNase Ti gene, was 
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digested with SphI and SuA (Fig. lb). The RNase Ti gene thus excis- 
ed was isolated from a 5% polyacrylamide gel after electrophoresis. 
The trp promoter-containing vector, the RNase Ti gene, and the syn- 
thetic gene for the APase signal peptide were mixed and incubated 
with T4 DNA ligase, and the desired plasma, termed pTPW1, was 
obtained from E. coli HBlOl transformants by standard procedures. 
pW58Al containing the gene for the (Glu-58 - Ala) mutant of 
RNase Ti was constructed from pTPW1 and pT58A 151. The 
nucleotide sequences of these fusion genes were confirmed by the 
dideoxy chain termination method [ 141. 
2.2. Expression in E. coli and purification of RNase TI 
E. coli HBlOl harboring pTPW1 (or pW58Al) was grown at 37°C 
in 4 liters of M9-casamino acid medium containing ampicillin 
(20 pg/ml). After incubation for 1.5 h (optical density of culture at 
660 nm, 0.05-O.l), 3-indoleacrylic acid (IAA, 40 pg/ml) was added 
to the medium to induce the expression of the fusion gene. Cells were 
allowed to grow further for 8 h, harvested by centrifugation (3500 x 
g, 10 min, 4°C). and washed in isotonic saline. Proteins in the 
periplasmic space were then released by osmotic-shock treatment by 
a modified version of the protocol of Cornelis et al. 1151. Thus, the 
saline-washed cells were suspended in 1 liter of 25% sucrose contain- 
ing 1 mM EDTA and 30 mM Tris-HCl (pH 8.0) and the suspension 
was shaken at 37°C for 30 min. The cells were then sedimented by 
centrifugation (14000 x g, 1 h, 2O”C), resuspended in 1 liter of ice- 
cold 20 mM Tris-HCl (pH 7.5), and shaken at 0°C for 30 min. The 
suspension was centrifuged (10008 x g, 15 min, 4’C) and the resul- 
tant supernatant was used as the periplasmic fraction. The 
cytoplasmic fraction was prepared from the sedimented cells by 
(a) 
disruption with lysozyme in the presence of SDS. RNase Ti (or its 
mutant) was purified from the periplasmic fraction by two steps of 
column chromatography: first, anion-exchange chromatography on a 
Q-Sepharose column equilibrated with 0.15 M NaCl in 20 mM Tris- 
HCl (pH 7.5) and eluted with a linear NaCl gradient (0.15-0.45 M) 
in 20 mM Tris-HCl (pH 7.5); then gel chromatography on a 
Sephadex G-50 column from which the enzyme was eluted with 
20 mM ammonium bicarbonate. The enzyme at each purification 
step was analyzed by SDS-PAGE. 
2.3. Other methods 
Protein was determined by Lowry method and in the case of the 
purified enzyme from the absorbance at 280 nm using an extinction 
coefficient of A?&, = 1.91 (16). 
RNase Ti activity was assayed by measuring the hydrolysis of 
[5 ’ -“P]pGpC as described previously [4]. 
3. RESULTS AND DISCUSSION 
A DNA duplex encoding the 21-residue signal pep- 
tide of E. coli APase was synthesized (Fig. la) and used 
for construction of the secretion plasmid pTPW1 for 
RNase T1 as shown in Fig. lb. E. coli HBlOl was 
transformed with this plasmid and the APase signal 
peptide-RNase Ti fusion gene was expressed by induc- 
ing the trp promoter with IAA. After incubation for 
8 h, the culture supernatant as well as the cytoplasmic 
Processing site 
Cla I 
AAA WA TCT an: ATT GCT CTG GCA CTC CTG C&i l7A CTG l-IT ACC CCFGTG 
Ll L2 
(b) 
pGH-L9 pPS,-Tl Signal Pe,ptide Gene 
Clal -Sal I SphI-Sal1 
1 DNA ligase 
pTPW1 
Fig. 1. Synthesis of the gene for the signal peptide of E. coli APase (a) and construction of the secretion plasmid pTPW1 (b). (a) Oligonucleotides 
termed UI, U2, Ll, and L2 were chemically synthesized and ligated enzymatically (ligation sites are shown by arrowheads) to give the synthetic 
gene. 001 and SphI sites were introduced at the 5’- and 3’-ends, respectively, to facilitate subsequent DNA manipulation. The amino acid 
sequence of the signal peptide and the processing site are also shown. (b) The procedures are self-explanatory. trpP, trp promoter; penP, 
penicillinase promoter; Pen-Signal, penicillinase signal peptide; and APase-Signal, APase signal peptide. 
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Fig. 2. SDS-PAGE (a, b) and PAGE under non-denaturing conditions (c) on 15% gels. (a) Periplasmic fractions of E. cob HBlOl/pTPWl grown 
in the absence (lane 1) and presence (lane 2) of IAA (40 fig/ml). (b) Authentic RNase Ti (lane 1). Periplasmic fraction of E. coli HBlOl/pTRWl 
grown in the presence of IAA (lane 2). Fraction obtained after Q-Sepharose chromatography of the periplasmic fraction (lane 3). Fraction 
obtained after Sephadex G-50 gel filtration of the Q-Sepharose fraction (lane 4). (c) PAGE under non-denaturing conditions. Authentic RNase 
Ti (lane 1). Purified recombinant RNase Ti (lane 2). Lane M, molecular mass markers (values in kDa on the left). The positions of RNase TI 
is indicated by arrowheads. Gels were stained with Coomassie brilliant blue. 
and periplasmic fractions (separated by osmotic shock 
treatment) of the cells were assayed for RNase Ti ac- 
tivity. High activity was detected only in the 
periplasmic fraction (data not shown). Upon SDS- 
PAGE the periplasmic fraction of the cells harboring 
pTPW1 exhibited a band having the same mobility as 
authentic RNase Ti and this band was induced by treat- 
ment of the cells with IAA (Fig. 2a). When the 
periplasmic fraction of the IAA-induced cells was sub- 
jected to Q-Sepharose column chromatography, this 
band was extensively purified (Fig. 2b, lane 3). Further 
purification of this sample by gel filtration through a 
Sephadex G-50 column yielded pure RNase Tt, which 
gave a single protein band both on SDS-PAGE 
(Fig. 2b, lane 4) and on PAGE under non-denaturing 
conditions (Fig. 1C). The yield of the pure protein was 
1.8 mg from 1 liter of culture. The purified enzyme 
showed the same specific activity as authentic RNase Ti 
(data not shown). The N-terminal sequence of the 
purified protein was determined to be Ala-X-Asp-Tyr- 
Thr-, which is identical with that of authentic RNase Ti 
[2]. These results indicate that the signal peptide-RNase 
Ti fusion protein synthesized in the cytoplasm was effi- 
ciently secreted into the periplasm with the aid of the 
APase signal peptide and the heterologous signal pep- 
tide was cleaved off at the correct site. 
Although RNase Ti is very stable, some of its 
mutants are labile. Especially the (Glu-58 - Ala) mu- 
tant is the most unstable among the mutants prepared 
in our laboratory. This mutant enzyme expressed in E. 
coli as a fusion protein with hGH-AB tends to undergo 
denaturation during purification procedures [5], mak- 
ing it difficult to obtain sufficient amounts of the pure 
protein. To test if this drawback can be overcome by 
using the secretion method, we constructed the secre- 
tion plasmid pW58Al for the mutant in the same way 
as for the wild-type enzyme. Expression in E. coli and 
purification of this mutant enzyme were conducted in 
the same way as for wild-type RNase Ti (data not 
shown). The yield of the pure mutant enzyme was 
2.0 mg from 1 liter of culture. This mutant has proven 
to be useful for studies of the reaction mechanism of 
RNase Ti [5]. 
In Table I the secretion method is compared with the 
previously used ‘fusion protein method’ with respect o 
the yield and purity of the enzyme at each step. As an 
example of the fusion protein method, the data for the 
(Tyr-45 - Trp) mutant of RNase Ti, which has a 
higher nucleolytic activity than the wild-type enzyme, 
are summarized [7]. Although a very high level of ex- 
pression is observed in the crude cell extract when the 
fusion method is used, the yield decreases drastically 
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Table I 
A summary of purification of wild-type RNase Ti expressed by the 
secretion method (a) and that of (Tyr-45 --+ Trp) mutant of RNase 
Ti expressed by the fusion protein method (b) 
(a) Wild-type (secretion method) 
Fraction Total protein 
(mg) 
RNase Ti 
(mg) 
Yield 
(%) 
Periplasmic fraction 70 4.0 100 
Q-Sepharose 7.0 2.1 53 
Sephadex G-50 1.8 1.8 45 
(b) (Tyr-45 --+ Trp) mutant (fusion protein method) 
Fraction Total protein Mutant RNase Ti Yield 
(mg) (mg) (o/o) 
Crude extract 243 11 (38)8 loo 
1st DE-52 75 3.6 (12)a 33 
2nd DE-52 3.6 0.74 6.7 
HPLC (DEAE-2SW) 0.13 0.13 1.2 
a Numbers in parentheses represent the amounts of the fusion 
protein present in the fractions. BrCN treatment of the fusion 
protein should theoretically liberate the mutant enzyme in amount 
shown without parentheses 
Purification was carried out from 1 liter of culture in both cases. The 
amount of enzyme in each fraction (except for the final preparation) 
was estimated from the catalytic activity. In (b), BrCN treatment was 
conducted after first DE52 chromatography. Data in (b) are from [7] 
during purification, especially after BrCN treatment, 
which was conducted after the first DE-52 column 
chromatography. In contrast, in the secretion method 
the gene product is secreted into the periplasmic space 
and thus separated from numerous cytoplasmic pro- 
teins. Therefore, it can be purified by a simple two-step 
procedure, without substantial oss. In addition, the 
gene product can be processed correctly during the 
secretion by the host, making it possible to avoid the 
drastic BrCN treatment. For these two reasons the final 
yield of pure RNase Ti achieved in the secretion 
method is much higher than in the fusion protein 
method, even though the level of expression is only 
moderate in the former method. 
As mentioned earlier, Quass et al. [lo] have reported 
the secretion of an RNase Tr analog into the periplasm 
of E. coli using the signal peptide of OmpA protein. In 
their enzyme, however, Glu-25 is replaced by Lys and 
there are 4 extra amino acids, Ala-Glu-Phe-Met, at the 
N-terminus as a result of their strategy for construction 
of the gene. Our expression method, in which RNase Tr 
is secreted in its intact form, appears to be particularly 
useful. 
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